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Summary
Background Health inequalities persist into old age. We aimed to investigate risk factors for socioeconomic differences 
in frailty that could potentially be modified through policy measures.
Methods In this multi-wave longitudinal cohort study (Whitehall II study), we assessed participants’ socioeconomic 
status, behavioural and biomedical risk factors, and disease status at age 45–55 years, and frailty (defined according to 
the Fried phenotype) at baseline and at one or more of three clinic visits about 18 years later (mean age 69 years 
[SD 5·9]). We used logistic mixed models to examine the associations between socioeconomic status and risk factors 
at age 50 years and subsequent prevalence of frailty (adjusted for sex, ethnic origin, and age), with sensitivity analyses 
and multiple imputation for missing data.
Findings Between Sept 9, 2007, and Dec 8, 2016, 6233 middle-aged adults were measured for frailty. Frailty was present 
in 562 (3%) of 16 164 person-observations, and varied by socioeconomic status: 145 (2%) person-observations had 
high socioeconomic status, 241 (4%) had intermediate status, and 176 (7%) had low socioeconomic status, adjusting 
for sex and age. Risk factors for frailty included cardiovascular disease, depression, smoking, high or abstinent alcohol 
consumption, low fruit and vegetable consumption, physical inactivity, poor lung function, hypertension, and 
overweight or obesity. Cardiometabolic markers for future frailty were high ratio of total to high-density lipoprotein 
cholesterol, and raised interleukin-6 and C-reactive protein concentrations. The five most important factors 
contributing to the frailty gradient, assessed by percent attenuation of the association between socioeconomic status 
and frailty, were physical activity (13%), interleukin-6 (13%), body-mass index category (11%), C-reactive protein (11%), 
and poor lung function (10%). Overall, socioeconomic differences in frailty were reduced by 40% in the maximally-
adjusted model compared with the minimally-adjusted model.
Interpretation Behavioural and cardiometabolic risk factors in midlife account for more than a third of socioeconomic 
differences in frailty. Our findings suggest that interventions targeting physical activity, obesity, smoking, and low-
grade inflammation in middle age might reduce socioeconomic differences in later-life frailty.
Funding British Heart Foundation and British Medical Research Council.
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
Frailty is a non-specific state of disorder in an individual’s 
physiological systems that manifests as fatigue, weakness, 
loss of balance, and mobility and cognitive impairment.1–3 
It is associated with older age, chronic disease, functional 
impairment, and future disability, and is the most 
common condition leading to death in community-
dwelling individuals.4 Frailty is the product of lifelong 
accumulation of biological damage and dysfunction, and 
its occurrence at the population level is greatest in 
individuals with low socioeconomic status and lowest in 
those with least socioeconomic disadvantage.5
To date, social inequalities in frailty have been 
documented with measures of wealth and neighbourhood 
deprivation and indices of relative deprivation including 
level of education over the life course, by use of a 
multidimensional frailty index.5,6 Studies that made use 
of a range of socioeconomic indices in relation to the 
frailty phenotype,1 first developed in the Cardiovascular 
Health Study, also show gradients in frailty.7–10 This 
inverse socioeconomic gradient is highly relevant to 
public health policy.11 However, there is little evidence on 
specific risk factors that might be targets for intervention 
to reduce socioeconomic differences in frailty.12
The inverse socioeconomic gradient in frailty in many 
countries is scientifically important in the current context 
of rapid global ageing.11 Socioeconomic gradients in 
health are preventable but persistent.12 With respect to 
frailty inequality, population ageing is likely to generate a 
large increase in poor functional health and dependency 
in populations of older people with socioeconomic dis-
advantage and thus those with fewer resources, unless 
prevention measures are successful.13,14 Current healthy 
ageing policy places emphasis on midlife approaches 
to prevention.11,15,16 However, the evidence for efficacy 
of such measures is incomplete. Previous studies 
examined risk factors measured at age 60 years or older, 
when intervention might be too late.8,9,17 This study 
Articles
2 www.thelancet.com/public-health   Published online June 13, 2018   http://dx.doi.org/10.1016/S2468-2667(18)30079-3
See Online for appendix
addresses this gap in the evidence by analysing the role in 
frailty inequality of behavioural and biomedical risk 
factors and disease status at age 50 years. Our aim was to 
examine the contribution of modifiable behavioural and 
biomedical risk factors and disease status at age 50 years 
to the occurrence of later life frailty and its socioeconomic 
gradient.
Methods
Study design and participants
In this prospective, cohort study, we analysed data from 
the Whitehall II study, a longitudinal cohort study of 
British civil servants.18 The study began in 1985 in 
participants aged 35–55 years, with repeated data 
collection every 2–3 years. Participants had a clinical 
screening of behavioural and biomedical factors in 
1985–88, 1991–94, 1997–99, 2002–04, 2007–09, 2012–13, 
and 2015–16 and additionally completed a questionnaire 
on behavioural risk factors in 1989–90, 1995–96, 2001, 
and 2006. The component measures of Fried’s frailty 
phenotype were measured at the fifth, sixth, and 
seventh clinic visits.1 The study was approved by the 
University College London Medical School Committee 
on the ethics of human research. All participants 
provided informed written consent.
Frailty
Frailty was defined according to the Fried method.1 The 
following five components were measured: walking 
speed,16 grip strength,19 weight loss, self-reported 
exhaustion, and energy expenditure from self-reported 
physical activity. Cutoff points for poor function on each 
component are given in the appendix (p 2) and were 
based on the report by Fried and colleagues.1 Frailty was 
defined by the presence of at least three frailty 
components and pre-frailty defined by one or two frailty 
components.
Socioeconomic status
Occupational class of each participant was based on the 
current or most recent Civil Service employment grade, 
at age 45–55 years. Employment grade characterised 
classes of individuals with similar income, pension 
rights, job security, and work skills, and was divided into 
high, intermediate, and low groups.
Behavioural and biomedical risk factors
Risk factor levels were based on measurements made at 
age 45–55 years. Behaviours (smoking, alcohol intake, 
physical activity, and fruit and vegetable intake) and 
biomedical risk factors (body-mass index, serum 
cholesterol, serum high-density lipoprotein (HDL) 
cholesterol, fasting plasma glucose, serum inter-
leukin-6 [IL-6] and C-reactive protein) were derived from 
self-reports and clinical data.20,21 Participants were 
assigned to three physical activity groups: inactive; less 
than 1 h per week of moderate and vigorous activity, 
2·5 h or more per week of moderate activity, or 1 h or 
more of vigorous activity; and moderately active. For lung 
function, we used the largest forced expiratory volume 
(FEV) in 1 s (measured in L) value of three attempts.22 
Lung volumes are related to body size, therefore we 
corrected FEV for height by dividing by the square of the 
participant’s standing height and multiplying by the 
square of the sample mean height, 1·77 m in men and 
1·63 m in women, so that variation in lung function was 
due to factors other than body size.23
Disease status and disability
Disease status was identified at age 45–55 years. 
Depressive symptoms were defined according to general 
health questionnaire caseness (GHQ-30, score ≥5), 
hypertension of at least 140 mm Hg systolic or at least 
90 mm Hg diastolic blood pressure or on antihypertensive 
treatment, diabetes based on a standard 75 g oral glucose 
Research in context
Evidence before this study
We searched PubMed for epidemiological studies of frailty with 
no restriction on study location, with the search terms “ageing”, 
”frailty”, ”prospective”, and ”socioeconomic” between 
June 28, and Sept 30, 2017, with no language restrictions. 
Additionally, we hand searched reference lists in relevant 
papers. Social inequalities in development of frailty in old age 
have been documented, using a range of socioeconomic 
indices, in many countries. However, evidence is scarce on the 
role of specific risk factors in midlife that might be targets for 
intervention to reduce the socioeconomic gradient in frailty.
Added value of this study
We examined a broad range of risk factors at age 50 years that 
might account for the socioeconomic differences in frailty 
(Fried phenotype) at median age 18 years later in the 
Whitehall II cohort study, according to Civil Service 
employment grade. The five most important contributing 
factors were low physical activity, poor lung function, high 
body-mass index, high serum interleukin-6, and high C-reactive 
protein. The examined risk factors together accounted for 
40% of the socioeconomic gradient in frailty.
Implications of all the available evidence
In light of rapid ageing of the global population, the observed 
inverse socioeconomic gradient in frailty is important, and 
relevant to public health policy. Interventions targeting physical 
inactivity, obesity, smoking, and low-grade inflammation in 
midlife might reduce socioeconomic differences in later-life 
frailty. Replication of our findings elsewhere is needed. The 
degree to which such policies would reduce frailty inequality 
depends on the assumption that the risks are reversible and 
that there is societal commitment to change the socioeconomic 
distribution of risk factors across the population.
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tolerance test or self-reported doctor diagnosis, and 
cardiovascular disease as non-fatal myocardial infarction 
or definite angina according to self-report, clinical data, 
and health records. Disability was defined as one or more 
impairments of six self-care tasks on the Activities of 
Daily Living (ADL) questionnaire: dressing, walking 
across the room, bathing or showering, eating, getting in 
or out of bed, and using the toilet.16
Statistical analysis
The study sample was defined as those who participated 
at the fifth (2007–09), sixth (2012–13), or seventh 
(2015–16) clinics and in whom frailty was assessed at 
least once. For each level of each risk factor, we calculated 
the number of individuals, total person-observations, 
and cases of frailty, together with the percentage of all 
observations that were considered cases of frailty. For 
each employment grade, we also calculated the per-
centage of observations that were cases of frailty from 
observations that fulfilled at least one of the five frailty 
conditions. Additionally, of the observations that were 
not cases of frailty, we calculated the percentage of 
observations that were cases of pre-frailty.
We used multiple imputation for missing risk factor 
data, replacing missing values with values drawn randomly 
from the predictive distribution of each risk factor 
conditional on the observed data as specified by an 
imputation model. This process created multiple imputed 
datasets that each had no missing values and accounted 
for the uncertainty due to the missing data. The imputation 
model contained all assessments of the participants’ frailty 
status together with all the risk factors at age 50 years as 
described previously.16 Additionally, the following auxiliary 
variables, which were associated with at least one of the 
risk factors with missing data, were included in the 
imputation model: data wave when participant was aged 
50 years; values of all the risk factors at ages below and 
above age 50 years from adjacent data collections; waist 
circumference; prevalent angina, myocardial infarction, 
stroke, and systolic and diastolic blood pressure; family 
history of high blood pressure; and satisfaction with 
standard of living. We generated ten imputed datasets that 
were analysed separately and combined the results using 
Rubin’s rules.24
We fitted logistic mixed models for frailty to estimate 
the associations between each risk factor at age 50 years 
and subsequent assessments of the frailty outcome. 
These models made use of data from all available clinic 
visits when frailty was measured while also accounting 
for differences in the timing of these occasions and the 
correlated nature of the data from repeated measures of 
Figure 1: Study profile
Full information about the number and proportion of participants with frailty 
measurements at each clinic is provided in the appendix (p 6).
10 038 patients assessed for 
eligibility
5965 had frailty assessed at 
2007–09 visit aged 
55–79 years
167 positive for frailty
5432 had frailty assessed at 
2012–13 visit aged 
60–82 years
185 positive for frailty
16 164 total person observations 
in 6233 participants with 
one or more frailty 
assessments
562 total observations with 
frailty in 449 participants
4075 excluded 
3081 no assessment of frailty
 924 no measurements at 
age 50 years
70 unknown ethnic origin
4767 had frailty assessed at 
2015–16 visit aged 
63–85 years
210 positive for frailty
Individuals Person-observations Positive 
observations for 
frailty adjusted for 
sex and age (%)*
Odds ratio† 
(95% CI)
Total sample 6233 16 164 562 (4%) ··
Age group at fifth clinic (2007–09), years
≤64 3235 8695 150 (2%) Ref (1·0)
65–69 1348 3526 128 (4%) 1·98 (1·51–2·59)
70–74 1269 3102 193 (6%) 3·70 (2·89–4·74)
≥75 381 841 91 (11%) 7·55 (5·44–10·5)
Sex
Male 4456 11 691 289 (3%) Ref (1·0)
Female 1777 4473 273 (6%) 2·42 (1·98–2·96)
Ethnic origin
White 5734 14 979 455 (3%) Ref (1·0)
South Asian 289 692 67 (8%) 2·95 (2·10–4·15)
Black 166 379 27 (5%) 1·91 (1·17–3·11)
Other 44 114 13 (9%) 3·58 (1·67–7·68)
Marital status
Married or cohabiting 4662 12 198 341 (3%) Ref (1·0)
Single, divorced, or 
widowed
1253 3171 195 (6%) 2·13 (1·71–2·65)
Missing 318 796 26 ··
Socioeconomic status (last known grade at age 50 years) 
High 2677 7204 145 (2%) Ref (1·0)
Intermediate 2764 7119 241 (4%) 1·48 (1·16–1·88)
Low 792 1841 176 (7%) 2·60 (1·89–3·58)
Data are n(%). *Age-adjusted (at the fifth clinic) and sex-adjusted prevalence of frailty for all characteristics. Values for 
sex are age-adjusted. †Odds ratios for each risk factor after multiple imputation for missing values, adjusted for age 
and age squared at the fifth clinic, time of frailty measure since fifth clinic, sex, and ethnic origin. 
Table 1: Presence of frailty at 2007–09, 2012–13, or 2015–16 visits, by sociodemographic characteristics 
in 6233 participants
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frailty from the same individual over time. For those 
attending the fifth clinic (2007–09), when frailty was first 
assessed, age was defined at the date of attendance. The 
timing of frailty measurements at the sixth and seventh 
clinics was accounted for by use of the interval since the 
fifth clinic as the time variable. For those who did not 
attend the fifth clinic, the midpoint date of that clinic was 
used to calculate age and the time variable. A random 
intercept was fitted to allow for individual differences in 
frailty at the fifth clinic.
The base model was initially adjusted for age and age 
squared at the fifth clinic, time of frailty measurement 
since the fifth clinic, sex, and ethnic origin to estimate 
odds ratios of frailty for each level of the risk factor 
relative to a reference level that was considered healthy. 
For the biomedical factors, we estimated the odds ratio of 
frailty per one standard deviation increase in each factor. 
To assess the potential contribution of each risk factor to 
the trend of increased frailty with lower employment 
grade, we added each factor separately into a base model, 
adjusted with the addition of a separate marital status 
term for each sex and employment grade and calculated 
the percentage change in the employment grade gradient 
compared with the base model. Furthermore, we adjusted 
for groups of risk factors a priori, and then for all risk 
factors together, to assess the amount of attenuation of 
the employment grade gradient. Predictors of impaired 
functioning in a previous study16 (lung function, hyper-
tension, physical inactivity, and inflammatory markers) 
were also grouped for adjustment.
We completed sensitivity analyses with logistic re-
gression and multiple imputation for missing risk factor 
values, using individuals rather than person-observations 
as the unit of analysis, by examining the associations of 
employment grade and the risk factors with ever having 
frailty one or more times, as assessed from the three clinics 
in 2007–09, 2012–13, and 2015–16. With these models we 
used bootstrap methods to compute 95% CI for the 
percentage attenuation in the employment grade effects.
We used the methods of Fine and Gray25 to adjust for 
the competing risk of attrition from our study before the 
seventh clinic by use of individuals as the unit of 
analysis in a time-to-event framework, incorporating a 
modification26 that real located participants with attrition 
to frailty cases according to their probability of becoming 
frail during the follow-up period. All analyses were done 
in SAS version 9.4.
Data sharing
Whitehall II data are available to bona fide researchers 
for research purposes. Please refer to the Whitehall II data 
sharing policy. Definition of variables and statistical 
codes are provided in the appendix (pp 3–5).
Role of the funding source
The funders of the study had no role in study design, 
data collection, data analysis, data interpretation, 
Figure 2: Age-standardised frailty and pre-frailty observations by employment grade and sex
Error bars show 95% CI. Figure shows age-standardised frailty (A) and pre-frailty (B) by employment grade and 
sex as a proportion of person-observations in the total population, and age-standardised frailty as a proportion 
of person-observations in those meeting at least one of the five frailty components (ie, excluding non-frail 
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Individuals (n=6233) Person-observations 
(n=16 164)
Positive observations for frailty 
adjusted for sex and age (%)*
Odds ratio† (95% CI)
Smoking status
Never smoker 2972 7870 292 (4%) Ref (1·0)
Ex-smoker 2211 5782 152 (3%) 0·85 (0·67–1·07)
Current smoker 679 1615 92 (5%) 1·69 (1·27–2·25)
Missing 371 897 26 ··
Alcohol consumption
None 893 2218 147 (5%) 1·85 (1·43–2·38)
Moderate (women: ≤ 14 units 
per week; men: ≤21 units per 
week)
3898 10 216 297 (3%) Ref (1·0)
High 1132 2981 91 (4%) 1·54 (1·17–2·04)
Missing 310 749 27 ··
Fruit and vegetable consumption
≥ Daily 3921 10 348 335 (3%) Ref (1·0)
< Daily 2011 5097 206 (4%) 1·29 (1·05–1·58)
Missing 301 719 21 ··
Physical activity
Active 3274 8584 202 (3%) Ref (1·0)
Moderately active 1307 3421 130 (4%) 1·52 (1·17–1·97)
Inactive 1258 3216 195 (6%) 2·63 (2·06–3·37)
Missing 394 943 35 ··
FEV (adjusted for height)
Tertile 1 (lowest; <2·91 L) 291 783 19 (2%)‡ 1·90 (1·36–2·65)
Tertile 2 (2·91–3·58 L) 297 829 10 (1%) 1·54 (1·25–1·90)
Tertile 3 (highest; >3·58 L) 299 843 4 (1%) Ref (1·0)
Missing 5346 13 709 529 ··
Per 1SD increase ·· ·· ·· 0·63 (0·55–0·72)
Adiposity
Underweight (<18·5 kg/m²) 38 102 5 (5%) 1·95 (0·67–5·66)
Normal weight  
(18·5–24·9 kg/m²)
2796 7363 217 (3%) Ref (1·0)
Overweight  
(25·0–25·9 kg/m²)
2173 5628 190 (3%) 1·34 (1·07–1·69)
Obese (≥ 30·0 kg/m²) 578 1444 117 (8%) 3·52 (2·62–4·72)
Missing 648 1627 33 ··
Depressive symptoms
No 4377 11 349 336 (3%) Ref (1·0)
Yes 1542 4062 198 (5%) 1·65 (1·33–2·03)
Missing 314 753 28 ··
Hypertension
No 4645 12 226 408 (3%) Ref (1·0)
Yes 1169 2944 137 (5%) 1·39 (1·10–1·76)
Missing 419 994 17 ··
Diabetes
No 6063 15 746 544 (3%) Ref (1·0)
Yes 170 418 18 (5%) 1·62 (0·92–2·88)
Cardiovascular disease
No 6091 15 819 543 (3%) Ref (1·0)
Yes 142 345 19 (8%) 2·11 (1·18–3·79)
Data are n (%). FEV=forced expiratory volume. *Age-adjusted (at the fifth clinic) and sex-adjusted prevalence of frailty, except for FEV for which unadjusted prevalence is shown. 
†Odds ratios for each risk factor after multiple imputation for missing values, adjusted for age and age-squared at the fifth clinic, time of frailty measure since fifth clinic, sex, and 
ethnic origin in 6233 participants. ‡For FEV tertiles, unadjusted prevalence is shown because the age range of this sample at the fifth clinic was restricted (all ages ≤64 years). 
Table 2: Presence of frailty at 2007–09, 2012–13 or 2015–16 by risk factors measured at age 50 years
For the Whitehall II data 
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or writing of the report. The corresponding author had 
full access to all the data in the study and had final 
responsibility for the decision to submit the manuscript 
for publication. 
Results
In 1985, 10 308 civil servants were entered into the 
Whitehall II study (figure 1); the maximum follow-up 
was from 1985 to 2016, with the median follow-up from 
age 50 years being 18·0 years (IQR 14·5–22·8). Between 
Sept 9, 2007, and Dec 8, 2016, frailty was assessed and 
found to be present in 562 (4%) of 16 164 person-
observations at mean age 69 years (SD 5·9) and varied by 
socioeconomic status: 145 (2%) person-observations had 
high socioeconomic status, 241 (4%) had intermediate 
status, and 176 (7%) had low socioeconomic status. Frailty 
was also associated with older age, female sex, and non-
white ethnic origin at age 50 years (table 1). Prevalence of 
the components of frailty, other than weight loss, 
increased with lower employment grade in the whole 
sample (appendix p 7). Among the 562 person-
observations with frailty, the only component showing a 
social gradient was walking speed in women (appendix 
p 8). In both sexes, there were gradients according to 
employment grade in the proportion of frailty and pre-
frailty overall, and in the proportion of frailty among 
person-observations defined as pre-frail or frail (figure 2). 
Disability, defined as one or more impairments as 
defined on the ADL questionnaire, was present more 
often in observations of frail individuals (278 [47%] of 
594 person-observations) than in observations of non-
frail or pre-frail individuals (1382 [9%] of 15 433 person-
observations).
After adjustment for age and sex, predictors of frailty at 
age 50 years included abstinence or high consumption of 
alcohol, current smoking status, low daily fruit and 
vegetable consumption, moderate or no physical activity, 
low lung function (measured by FEV), overweight and 
obesity, depressive symptoms, hypertension, and 
cardiovascular disease (table 2); being an ex-smoker, 
underweight, or having a diagnosis of diabetes did not 
significantly affect frailty risk. Blood biomarker risk 
factors for frailty (measured at age 50 years) were low 
HDL cholesterol, low ratio of total to HDL cholesterol, 
and high concentrations of IL-6 and C-reactive protein 
(table 3).
We examined the nature of the association of last known 
employment grade at age 50 years with frailty. The effect 
of adjustment of a base model for each potential 
contributing factor was analysed in turn (table 4). 
Comparison of the prevalence of risk factors by 
employment grade at the start of the study in the analytic 
sample, and those excluded from the sample, revealed 
evidence of health-related selection but similar risk 
factor trends by grade (appendix p 9). Attenuation of 
the grade–frailty association was more than 4% 
after model adjustment for smoking status, alcohol 
consumption, lung function as measured by FEV, body-
mass index category, HDL cholesterol concentration, ratio 
of total cholesterol to HDL cholesterol, and IL-6 and 
C-reactive protein concentrations. Risk factor attenuations 
were similar in men and women except for alcohol 
consumption, physical activity, and lung function 
(appendix p 10), with alcohol accounting for greater 
attenuation in women and physical activity and FEV 













Tertile 1 (<5·60) 1875 4992 152 (3%) Ref (1·0)
Tertile 2 (5·60–6·50) 2007 5247 195 (4%) 1·07 (0·84–1·38)
 Tertile 3 (>6·50) 1914 4887 191 (3%) 1·04 (0·81–1·34)
Missing 437 1038 24 ··
Per SD increase ·· ·· ·· 1·03 (0·93–1·14)
HDL cholesterol, mmol/L
Tertile 1 (<1·25) 1453 3855 103 (4%) 1·57 (1·16–2·12)
Tertile 2 (1·25–1·59) 1383 3695 113 (4%) 1·28 (0·96–1·71)
Tertile 3 (>1·59) 1492 4002 117 (3%) Ref (1·0)
Missing 1905 4612 229 ··
Per SD increase ·· ·· ·· 0·81 (0·71–0·93)
Total cholesterol:HDL cholesterol ratio
Tertile 1 (<1·31) 1442 3883 110 (3%) Ref (1·0)
Tertile 2 (1·31–1·57) 1442 3870 95 (4%) 1·08 (0·78–1·50)
Tertile 3 (>1·57) 1442 3793 128 (5%) 1·64 (1·22–2·19)
Missing 1907 4618 229 ··
Per SD increase ·· ·· ·· 1·20 (1·07–1·36)
Fasting glucose, mmol/L‡
Tertile 1 (<4·90) 1159 3162 68 (2%) Ref (1·0)
Tertile 2 (4·90–5·29) 1271 3457 71 (3%) 1·07 (0·72–1·58)
Tertile 3 (>5·29) 1245 3373 68 (3%) 1·12 (0·80–1·57)
Missing 2558 6172 355 ··
Per SD increase ·· ·· ·· 1·04 (0·95–1·14)
Interleukin-6 concentration, pg/mL
Tertile 1 (<1·06) 1245 3570 32 (1%) Ref (1·0)
Tertile 2 (1·06–1·63) 1215 3372 82 (3%) 1·73 (1·23–2·44)
Tertile 3 (>1·63) 1237 3088 103 (4%) 2·23 (1·59–3·13)
Missing 2536 6134 345 ··
Per SD increase ·· ·· ·· 1·41 (1·26–1·57)
C-reactive protein concentration, mg/L
Tertile 1 (<0·56) 1235 3581 50 (2%) Ref (1·0)
Tertile 2 (0·56–1·37) 1229 3382 56 (2%) 1·14 (0·83–1·56)
Tertile 3 (>1·37) 1245 3096 110 (4%) 1·94 (1·47–2·56)
Missing 2524 6105 346 ··
Per SD increase ·· ·· ·· 1·36 (1·21–1·53)
Data are n(%). HDL=high-density lipoprotein. *Age-adjusted (at the fifth clinic) and sex-adjusted prevalence of frailty. 
†Odds ratios of frailty associated with each biomedical factor after multiple imputation for missing values, adjusted for 
age and age squared at fifth clinic, time of frailty measure since fifth clinic, sex, and ethnic origin, in 6233 participants. 
‡Fasting glucose was measured in patients without diabetes only.
Table 3: Presence of frailty at 2007–09, 2012–13 or 2015–16 by biomedical factors measured at age 50 years
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Table 5 shows the effect of adjustment for six groups of 
risk factors. Adding body-mass index to the behavioural 
group of risk factors increased the attenuation of the 
socioeconomic gradient in frailty from 23% to 30%. 
Adjustment for prevalent disease at age 50 years 
(ie, cardiovascular disease, diabetes, and depressive 
symptoms) had little effect on the association. Adjustment 
for inflammatory markers as well as hypertension, 
physical activity, and lung function increased attenuation 
of the gradient in frailty from 22% to 33%. Adjustment 
for all covariates produced an attenuation of 39%. 
Sensitivity analysis showed physical activity but not body-
mass index contributed substantially to the attenuation 
when removed from the adjustment. Attenuation on 
adjustment for groups of risk factors tended to be larger 
in men than women (appendix p 11). There was no 
interaction of the frailty effects of employment grade and 
the other risk factors with age.
Further sensitivity analysis with logistic regression 
using individuals, rather than person-observations, as the 
unit of analysis produced similar findings for the frailty 
gradient and risk factor attenuations whether adjusted for 
singly or in groups (appendix pp 12–13). Bootstrap 
95% CIs were estimated for the percent changes in the 
employment grade effects in this mode of analysis. 
Generally, an attenuation of more than 4% was associated 
with a confidence interval that excluded the null, and thus 
a significant attenuation. The competing risks analysis 
suggested the trend in frailty by employment grade was 
slightly underestimated as a consequence of sample 
attrition. There were 282 deaths among non-frail 
participants before the seventh clinic (2015–16) when 
frailty was last assessed. Additionally, 1035 non-frail 
participants were not assessed after the fifth (2007–09) or 
sixth (2012–13) clinic. The proportion of loss to follow-up 
by employment grade differed considerably for drop-out 
but not for death (appendix p 14). We reassigned 
111 (8%) drop-outs from the non-frail group to the frail 
category on the basis of a propensity score of more than 
67% of the scores of observed frailty cases. The trend in 
frailty on employment grade was increased by 5%.
Discussion
Socioeconomic status shapes midlife exposure to many 
risk factors for poor health.27,28 Accordingly, in this 
prospective cohort study, we found a socioeconomic 
gradient in frailty at ages 55–85 years, defined on the basis 
of occupation at age 50 years. Health behaviours and 
biomedical risk factors measured at age 50 years accounted 
for more than a third of socioeconomic inequality in 
frailty. The five most important contributing factors that 
individually accounted for 10% or more of the 
socioeconomic gradient in frailty were physical activity 
level, lung function by spirometry, body-mass index 
category, and serum IL-6 and C-reactive protein 
concentrations. These observations provide evidence that 
midlife might be an appropriate age for public health and 
clinical interventions intended to reduce socioeconomic 
inequality in the functional health of older people as well 
as to reduce the number of frail older people. The analyses 
provide an estimate, making assumptions about 
reversibility of the risks, of the upper bound for attenuation 
of the social gradient in frailty that might be possible as a 
result of intervening on the risk factors identified.
We previously determined the associations of risk 
factors at age 50 years for impaired physical and cognitive 
functioning at older ages in the same setting.16 Physical 
inactivity, hypertension, and poor lung function stood out 
as potential midlife intervention targets to reduce 
likelihood of both types of functional impairment in old 
age. In this study, we used frailty, an outcome that is 
functionally related to but distinct from the Mini-Mental 
State Examination and ADL instruments used in our 
previous analysis. Our novel analysis with 18 years’ 
median follow-up confirms the importance of physical 
inactivity, hypertension, and poor lung function in midlife 
as risk factors for poor functional health at older ages.
Of the different frailty operationalisations, we used the 
well-known standard frailty phenotype,29 identified at one 
or more of three follow-up visits. The phenotype is an index 
of physical functioning, low vitality (ie, exhaustion), and 
recent weight loss; cognitive function is not included in 
the definition. We observed the expected association 
between frailty and disability. Low energy expenditure 
from physical activity is one of the five frailty criteria, 
Odds ratio (95% CI)* Percent change†
Base model‡ 1·49 (1·27–1·75) Ref (1·00)
Base model + smoking status 1·46 (1·24–1·72) –4·6%
Base model + alcohol consumption 1·45 (1·23–1·70) –7·0%
Base model + frequency of fruit or vegetable consumption 1·47 (1·25–1·73) –2·8%
Base model + physical activity 1·41 (1·20–1·66) –13·4%
Base model + FEV 1·43 (1·22–1·68) –10·0%
Base model + body-mass index category 1·42 (1·21–1·68) –11·0%
Base model + depressive symptoms 1·51 (1·28–1·77) +3·5%
Base model + hypertension 1·49 (1·27–1·75) +0·6%
Base model + diabetes 1·48 (1·26–1·74) –0·6%
Base model + cardiovascular disease 1·48 (1·26–1·74) –1·1%
Base model + total cholesterol 1·49 (1·27–1·75) +0·1%
Base model + HDL cholesterol 1·45 (1·23–1·71) –6·3%
Base model + total cholesterol:HDL ratio 1·46 (1·24–1·72) –4·7%
Base model + fasting glucose§ 1·50 (1·27–1·77) +1·6%
Base model + interleukin-6 concentration 1·41 (1·20–1·66) –13·0%
Base model + C-reactive protein concentration 1·43 (1·21–1·68) –10·6%
FEV=forced expiratory volume in 1 s. *Odds ratios of frailty from trend with last known grade on one degree of 
freedom (ie, the odds ratio of frailty for one unit lower grade level, across low, intermediate, and high employment 
grades) in 6233 participants. †Percentage change in coefficient (log odds ratio) for trend across employment grade, 
compared with the base model. A negative change indicates attenuation of the social gradient compared with the base 
model. ‡Base model is adjusted for age and age squared at fifth clinic, time of frailty measure since fifth clinic, sex, 
ethnic origin, marital status, and marital status by sex interaction. §Fasting glucose was measured in patients without 
diabetes only.
Table 4: Effect of adjustment of the base model for each potential contributing factor on the association 
of frailty at 2007–09, 2012–13, or 2015–16, with last known employment grade at age 50 years
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and (as expected) physical activity level, particularly physical 
inactivity, at age 50 years was a risk factor for frailty.16,30 
Physical activity level at age 50 years is also an important 
contributor to the socioeconomic difference in frailty, 
reflecting the association of inactivity with lower 
employment grade and conversely of higher physical 
activity with higher grade in midlife in the present study. 
The social gradient in physical activity level continues at 
older ages but the inverse trend in frailty occurrence across 
socioeconomic strata is not generated by the physical 
activity component. Some 90% of frailty cases met the 
physical inactivity criterion, the distribution of which 
among cases did not differ by employment grade.
Likewise, weight loss is one of the frailty criteria, and 
body-mass index at age 50 years is a risk factor. Potentially, 
high body-mass index in midlife, and associated later 
weight loss, could be responsible for distortion of frailty 
occurrence due to regression to the mean. However, 
few person-observations met the weight-loss criterion 
(loss >10% over 5 years) for frailty at follow-up and there 
was an even distribution of weight loss, thus defined, 
among frailty cases across employment grades in men 
and women.
Frailty can accompany or be a precursor to partial or 
total dependence on caregiver support.10,11,13,15,31 Reversing 
damage to the physiological systems underlying the 
frailty phenotype might not be feasible once it has 
developed. For example, poor lung function in chronic 
obstructive pulmonary disease is at best partly reversible.32 
In the present study, ex-smokers at age 50 years did 
not have increased odds of frailty compared with 
never-smokers, but current smokers did have higher odds 
of frailty. Thus, lung function is an important target of 
intervention in early adulthood and midlife, whereas 
increased physical activity is likely to yield benefits for 
health-related functioning, including mobility, among 
those able to adopt it, even at older ages. Both overweight 
and obesity at age 50 years increased the odds of frailty at 
older ages.33 It could be that intentional weight loss, as a 
result of calorie restriction or increased physical activity, 
is protective for frailty. By contrast, unintentional loss of 
weight is one of the five components defining frailty, and 
is fairly common in older adults.34
The key variables accounting for the socioeconomic 
gradient in frailty differed partly from those found to be 
risk factors for frailty overall. Physical inactivity, low FEV, 
and raised body-mass index were important mediators of 
the gradient as well as having main effects. Adjusting for 
IL-6 and C-reactive protein as well as hypertension, 
physical inactivity, and low FEV, led to further marked 
attenuation of the socioeconomic gradient in frailty, in 
line with the role of serum C-reactive protein 
concentration in predicting ADL disability.16 Although 
hypertension was a risk factor for frailty, controlling for it 
scarcely changed the coefficient for employment grade. 
Likewise, depression and cardio-vascular disease status at 
age 50 years were frailty risk factors but neither accounted 
for its socioeconomic gradient. Smoking at age 50 years 
both was a risk factor for frailty and accounted for 5% of 
the gradient in frailty. As noted above, in terms of frailty 
risk reduction in midlife, risk was similar among 
ex-smokers and never-smokers at age 50 years.
Model adjustments Odds ratio* (95% CI) Percent 
change†
Base model Age at fifth clinic, age squared, sex, ethnic origin, marital status, marital status by sex interaction, 
and interval between the fifth clinic visit and subsequent visits when frailty was measured
1·49 (1·27–1·75) Ref (1·00)
Health behaviours Base model plus smoking status, alcohol use, physical activity, and fruit or vegetable consumption 1·36 (1·15–1·61) –22·9%
Health behaviours plus body-mass index Base model plus smoking status, alcohol use, physical activity, fruit or vegetable consumption, or 
body-mass index
1·32 (1·11–1·56) –30·4%
Disease status Base model plus prevalent cardiovascular disease, diabetes, and depressive symptoms 1·50 (1·27–1·76) +1·7%
Predictors of impaired functioning
Cognitive and physical functioning Base model plus hypertension, physical activity, and FEV 1·36 (1·16–1·61) –21·6%
Cognitive, physical functioning, and 
inflammatory markers
Base model plus hypertension, physical activity, FEV, and inflammatory markers (C-reactive protein 
and interleukin-6)
1·30 (1·10–1·54) –33·4%
All covariates Base model plus smoking status, alcohol use, physical activity, fruit or vegetable consumption, 
body-mass index, hypertension, physical activity, FEV, inflammatory markers, HDL, prevalent 
cardiovascular disease, diabetes, and depressive symptoms
1·28 (1·07–1·51) –38·7 %
Sensitivity analysis
All covariates, excluding physical activity Base model plus smoking, alcohol use, fruit or vegetable consumption, body-mass index, hypertension, 
FEV, inflammatory markers, HDL, prevalent cardiovascular disease, diabetes, and depressive symptoms
1·31 (1·10–1·56) –31·7%
All covariates, excluding body-mass index Base model plus smoking, alcohol use, physical activity, fruit or vegetable consumption, hypertension, 
FEV, inflammatory markers, HDL, prevalent cardiovascular disease, diabetes, and depressive symptoms
1·28 (1·08–1·52) –37·3%
All covariates, excluding physical activity 
and body-mass index
Base model plus smoking, alcohol use, fruit or vegetable consumption, hypertension, FEV, 
inflammatory markers, HDL, prevalent cardiovascular disease, diabetes, and depressive symptoms
1·32 (1·11–1·57) –29·7%
FEV=forced expiratory volume in 1 s. HDL=high-density lipoprotein. *Odds ratios of frailty from trend with last known grade on one degree of freedom (ie, the odds ratio of frailty for one unit lower grade level, 
across low, intermediate, and high employment grades) in 6233 participants. †Percentage change in coefficient (log odds ratio) for trend across employment grade, compared with the base model. 
Table 5: Effect of adjustment for potential contributing factors on the association of frailty at 2007–09, 2012–13, or 2015–16 visits with trend in last known employment grade at age 50 years
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We found that about a third of socioeconomic inequality 
in frailty at older ages was accounted for by health 
behaviours and cardiovascular risk factors measured at 
age 50 years. The analysis was based on a relatively 
privileged population sample, largely composed of office-
based civil servants.18 Although their health status is 
better than that of participants in a general non-
occupational cohort in terms of mortality, morbidity, and 
risk factor distributions, causal associations between risk 
factors and incidental disease are generalisable.35 The 
analytical sample had favourable proportions of risk 
factors compared with those who dropped out or died 
before providing a frailty assessment. Associations of 
risk factors with employment grade were broadly similar. 
Considering the absence of manual workers in the 
Whitehall II cohort, perhaps the proportion of the 
socioeconomic gradient in frailty estimated by adjusting 
for the risk factors we studied (roughly a third) would be 
larger in the general population. This statistical approach 
is equivalent to standardising the risk factor distributions 
across the sample, and does not take account of the 
effectiveness of intervention in practice.
How is the unexplained proportion of the frailty 
gradient to be understood? First, we focused on midlife 
behaviours, chronic disease, and biomedical risk factors, 
although risk and protective factors in early life might 
also have a role in socioeconomic differences in frailty. 
Neither childhood socioeconomic circumstances nor 
health-related social selection were examined; however, 
both pathways have been shown to be modest in size 
compared with adult social causation.27,36 Depressive 
symptoms in this cohort did not contribute to the social 
gradient in frailty, and other midlife psychosocial risk 
factors such as job stress were not analysed.8,37–39 Second, 
exposure was assessed at a single point in midlife and 
biological risk accumulation over the life course was 
therefore measured suboptimally.40,41 Third, changes 
in disease and risk factor status before exposure 
assessment or after exposure assessment and before 
onset of frailty were not included in the analysis. Further 
research on the potential of modifiable early-life and 
old-age factors to reduce the socioeconomic gradient in 
frailty is needed.
The study has several defining characteristics. We did a 
prospective analysis of the associations of employment 
grade, and behavioural, biomedical, and disease exposures 
around age 50 years with occurrence of frailty 
approximately 18 years later. The inverse association of 
lower employment grade with risk of frailty was seen 
across the whole age range (55–85 years). Some risk factor 
effects on frailty were marginally weaker in older 
participants; however, these differences were small and 
there were no significant interactions with age. Missing 
risk factor data, but not outcome data, were filled in using 
multiple imputation. This procedure assumes the missing 
data are missing at random. The overall prevalence of 
frailty was 3%, which is close to the level in the 
corresponding age group in the Cardiovascular Health 
Study1 used to develop the definition of the frailty 
phenotype. Competing risks analysis, taking account of 
differing rates of death and loss to follow-up by 
employment grade in non-frail individuals, indicated that 
the observed socioeconomic gradient in frailty was slightly 
attenuated by sample attrition.
In conclusion, this study sought to quantify the 
potential contribution of modifiable risk factors at age 
50 years to later-life inequalities in frailty. Risk factors for 
socioeconomic inequality in frailty differed from those 
for frailty in the whole sample. For example, hypertension 
was a predictor of frailty overall but did not contribute to 
frailty inequality. Behaviour-related factors accounted for 
30% of the socioeconomic gradient, particularly smoking, 
alcohol consumption, physical activity, fruit and vegetable 
consumption, and body-mass index. Addition of lung 
function and inflammatory markers to this group of 
predictors attenuated the socioeconomic gradient by a 
further third, to 40%. Our findings suggest that frailty, 
and socioeconomic inequality in frailty, could at least 
partly be avoidable. Further research is needed to address 
other factors, including perceived control over health,39 
that might explain social differences in this important 
measure of wellbeing in older people.
Contributors
EJB, MJS, and MK developed the original idea for the manuscript. 
MJS analysed the data. EJB wrote the manuscript with MJS. EJB, MK, 
and AS-M are principal investigators of the Whitehall II study. 
All authors contributed to interpreting the results, reviewed and edited 
the manuscript and contributed to the discussion.
Declaration of interests
We declare no competing interests.
Acknowledgments
We thank all participating civil service departments and their welfare, 
personnel, and establishment officers; the British Occupational Health 
and Safety Agency; the British Council of Civil Service Unions; 
all participating civil servants in the Whitehall II study; and all members 
of the Whitehall II study team. The Whitehall II Study team comprised 
research scientists, statisticians, study coordinators, nurses, data managers, 
administrative assistants, and data entry staff, who made the study 
possible. The Whitehall II study is supported by grants from the 
British Heart Foundation (RG/13/2/30098, RG/16/11/32334), and British 
Medical Research Council (K013351).
References
1 Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: 
evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 
56: M146–56.
2 Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in 
elderly people. Lancet 2013; 381: 752–62.
3 Papachristou E, Wannamethee SG, Lennon LT, et al. Ability of 
self-reported frailty components to predict incident disability, falls, 
and all-cause mortality: results from a population-based study of 
older British men. J Am Med Dir Assoc 2017; 18: 152–57.
4 Gill TM, Gahbauer EA, Han L, Allore HG. Trajectories of disability 
in the last year of life. N Engl J Med 2010; 362: 1173–80.
5 Herr M, Robine JM, Aegerter P, Arvieu JJ, Ankri J. Contribution of 
socioeconomic position over life to frailty differences in old age: 
comparison of life-course models in a French sample of 2350 old 
people. Ann Epidemiol 2015; 25: 674–80.
6 Biritwum RB, Minicuci N, Yawson AE, et al. Prevalence of and 
factors associated with frailty and disability in older adults from 
China, Ghana, India, Mexico, Russia and South Africa. 
Maturitas 2016; 91: 8–18.
Articles
10 www.thelancet.com/public-health   Published online June 13, 2018   http://dx.doi.org/10.1016/S2468-2667(18)30079-3
7 Etman A, Burdorf A, Van der Cammen TJ, Mackenbach JP, 
Van Lenthe FJ. Socio-demographic determinants of worsening in 
frailty among community-dwelling older people in 11 European 
countries. J Epidemiol Community Health 2012; 66: 1116–21.
8 Hoogendijk EO, van Hout HP, Heymans MW, et al. Explaining the 
association between educational level and frailty in older adults: 
results from a 13-year longitudinal study in the Netherlands. 
Ann Epidemiol 2014; 24: 538–44.
9 Soler-Vila H, Garcia-Esquinas E, Leon-Munoz LM, Lopez-Garcia E, 
Banegas JR, Rodriguez-Artalejo F. Contribution of health behaviours 
and clinical factors to socioeconomic differences in frailty among 
older adults. J Epidemiol Community Health 2016; 70: 354–60.
10 Bandeen-Roche K, Seplaki CL, Huang J, et al. Frailty in older adults: 
a nationally representative profile in the United States. 
J Gerontol A Biol Sci Med Sci 2015; 70: 1427–34.
11 Beard JR, Officer A, de Carvalho IA, et al. The World report on ageing 
and health: a policy framework for healthy ageing. Lancet 2016; 
387: 2145–54.
12 Mackenbach JP. The persistence of health inequalities in modern 
welfare states: the explanation of a paradox. Soc Sci Med 2012; 
75: 761–69.
13 Guzman-Castillo M, Ahmadi-Abhari S, Bandosz P, et al. 
Forecasted trends in disability and life expectancy in England and 
Wales up to 2025: a modelling study. Lancet Public Health 2017; 
2: e307–13.
14 Kingston A, Wohland P, Wittenberg R, et al. Is late-life dependency 
increasing or not? A comparison of the Cognitive Function and 
Ageing Studies (CFAS). Lancet 2017; 390: 1676–84.
15 NICE. National Institute for Health and Care Excellence: dementia, 
disability and frailty in later life—mid-life approaches to delay or 
prevent onset. NICE Guidelines 2015; www.nice.org.uk/guidance/
ng16 (accessed May 17, 2018).
16 Brunner EJ, Welch CA, Shipley MJ, Ahmadi-Abhari S, 
Singh-Manoux A, Kivimaki M. Midlife risk factors for impaired 
physical and cognitive functioning at older ages: a cohort study. 
J Gerontol A Biol Sci Med Sci 2017; 72: 237–42.
17 Frost R, Belk C, Jovicic A, et al. Health promotion interventions for 
community-dwelling older people with mild or pre-frailty: 
a systematic review and meta-analysis. BMC Geriatr 2017; 17: 157.
18 Marmot M, Brunner E. Cohort profile: the Whitehall II study. 
Int J Epidemiol 2005; 34: 251–56.
19 Elbaz A, Shipley MJ, Nabi H, Brunner EJ, Kivimaki M, 
Singh-Manoux A. Trajectories of the Framingham general 
cardiovascular risk profile in midlife and poor motor function later 
in life: the Whitehall II study. Int J Cardiol 2014; 172: 96–102.
20 Brunner EJ, Marmot MG, Nanchahal K, et al. Social inequality in 
coronary risk: central obesity and the metabolic syndrome. 
Evidence from the Whitehall II study. Diabetologia 1997; 40: 1341–49.
21 Gimeno D, Brunner EJ, Lowe GDO, Rumley A, Marmot MG, 
Ferrie JE. Adult socioeconomic position, C-reactive protein and 
interleukin-6 in the Whitehall II prospective study. 
Eur J Epidemiol 2007; 22: 677–83.
22 Miller MR, Crapo R, Hankinson J, et al. General considerations for 
lung function testing. Eur Respir J 2005; 26: 153–61.
23 Xu X, Laird N, Dockery DW, Schouten JP, Rijcken B, Weiss ST. 
Age, period, and cohort effects on pulmonary function in a 24-year 
longitudinal study. Am J Epidemiol 1995; 141: 554–66.
24 Rubin D. Multiple imputation for nonresponse in surveys. 
New York City, NY: Wiley, 1987.
25 Fine JP, Gray RJ. A Proportional hazard model for the 
subdistribution of a competing risk. J Am Stat Assoc 1999; 
94: 496–509.
26 Chang CC, Zhao Y, Lee CW, Ganguli M. Smoking, death, and 
Alzheimer disease: a case of competing risks. 
Alzheimer Dis Assoc Disord 2012; 26: 300–06.
27 Brunner EJ, Shipley MJ, Blane D, Davey Smith G, Marmot MG. 
When does cardiovascular risk start? Past and present 
socioeconomic circumstances and risk factors in adulthood. 
J Epidemiol Community Health 1999; 53: 757–64.
28 Langenberg C, Kuh D, Wadsworth ME, Brunner E, Hardy R. 
Social circumstances and education: life course origins of social 
inequalities in metabolic risk in a prospective national birth cohort. 
Am J Public Health 2006; 96: 2216–21.
29 Bouillon K, Kivimaki M, Hamer M, et al. Measures of frailty in 
population-based studies: an overview. BMC Geriatr 2013; 13: 64.
30 Lafortune L, Martin S, Kelly S, et al. Behavioural risk factors in 
mid-life associated with successful ageing, disability, dementia and 
frailty in later life: a rapid systematic review. PLoS One 2016; 
11: e0144405.
31 Baker K. Commission on the future of health and social care in 
england. a new settlement for health and social care. London: 
The King’s Fund, 2014.
32 Mannino DM, Watt G, Hole D, et al. The natural history of chronic 
obstructive pulmonary disease. Eur Respir J 2006; 27: 627–43.
33 Kuh D, Bassey EJ, Butterworth S, Hardy R, Wadsworth ME. 
Grip strength, postural control, and functional leg power in a 
representative cohort of British men and women: associations with 
physical activity, health status, and socioeconomic conditions. 
J Gerontol A Biol Sci Med Sci 2005; 60: 224–31.
34 Albanese E, Strand BH, Guralnik JM, Patel KV, Kuh D, Hardy R. 
Weight loss and premature death: the 1946 British birth cohort 
study. PLoS One 2014; 9: e86282.
35 Batty GD, Shipley M, Tabak A, et al. Generalizability of occupational 
cohort study findings. Epidemiology 2014; 25: 932–33.
36 Elovainio M, Ferrie JE, Singh-Manoux A, et al. 
Socioeconomic differences in cardiometabolic factors: 
social causation or health-related selection? Evidence from the 
Whitehall II Cohort Study, 1991–2004. Am J Epidemiol 2011; 
174: 779–89.
37 Kalousova L, Mendes de Leon C. Increase in frailty of older workers 
and retirees predicted by negative psychosocial working conditions 
on the job. Soc Sci Med 2015; 124: 275–83.
38 Gardiner PA, Mishra GD, Dobson AJ. The effect of socioeconomic 
status across adulthood on trajectories of frailty in older women. 
J Am Med Dir Assoc 2016; 17: 372.
39 Mooney CJ, Elliot AJ, Douthit KZ, Marquis A, Seplaki CL. Perceived 
control mediates effects of socioeconomic status and chronic stress 
on physical frailty: findings from the health and retirement study. 
J Gerontol B Psychol Sci Soc Sci 2016; published online Aug 13. 
DOI: 10.1093/geronb/gbw096.
40 Alvarado BE, Zunzunegui MV, Beland F, Bamvita JM. Life course 
social and health conditions linked to frailty in Latin American 
older men and women. J Gerontol A Biol Sci Med Sci 2008; 
63: 1399–06.
41 Seeman TE, Crimmins E, Huang MH, et al. Cumulative biological 
risk and socio-economic differences in mortality: MacArthur studies 
of successful aging. Soc Sci Med 2004; 58: 1985–97.
